Literature DB >> 16780947

Establishment of a novel B-cell lymphoma cell line with suppressed growth by gamma-secretase inhibitors.

Shuji Tohda1, Taku Sato, Hanae Kogoshi, Lu Fu, Seiji Sakano, Nobuo Nara.   

Abstract

A novel lymphoma cell line, designated TMD8 was established from cells of a patient with diffuse large B-cell lymphoma. TMD8 cells expressed HES1 mRNA, suggesting constitutive activation of Notch signaling. TMD8 cells expressed normal-sized Notch1 protein, and showed no mutations in the NOTCH1 gene. Cell growth was suppressed by gamma-secretase inhibitors (GSI). It was reported that GSI suppressed growth of T-cell acute lymphoblastic leukemia (T-ALL) cell lines, which frequently had NOTCH1 mutations. In addition to T-ALL, TMD8 is another unique cell line sensitive to GSI, and is useful to study effects of GSI in molecular targeting therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16780947     DOI: 10.1016/j.leukres.2006.05.003

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  13 in total

Review 1.  Therapeutic approaches to modulating Notch signaling: current challenges and future prospects.

Authors:  Casper Groth; Mark E Fortini
Journal:  Semin Cell Dev Biol       Date:  2012-01-30       Impact factor: 7.727

2.  B cells with aberrant activation of Notch1 signaling promote Treg and Th2 cell-dominant T-cell responses via IL-33.

Authors:  Hiroshi Arima; Momoko Nishikori; Yasuyuki Otsuka; Wataru Kishimoto; Kiyotaka Izumi; Koubun Yasuda; Tomohiro Yoshimoto; Akifumi Takaori-Kondo
Journal:  Blood Adv       Date:  2018-09-25

Review 3.  Mechanisms and clinical prospects of Notch inhibitors in the therapy of hematological malignancies.

Authors:  Yulia Nefedova; Dmitry Gabrilovich
Journal:  Drug Resist Updat       Date:  2008-10-31       Impact factor: 18.500

4.  Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms.

Authors:  Yibin Yang; Roland Schmitz; Joseph Mitala; Amanda Whiting; Wenming Xiao; Michele Ceribelli; George W Wright; Hong Zhao; Yandan Yang; Weihong Xu; Andreas Rosenwald; German Ott; Randy D Gascoyne; Joseph M Connors; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Rita M Braziel; Raymond R Tubbs; James R Cook; Dennis D Weisenburger; Wing C Chan; Adrian Wiestner; Michael J Kruhlak; Kazuhiro Iwai; Federico Bernal; Louis M Staudt
Journal:  Cancer Discov       Date:  2014-02-03       Impact factor: 39.397

5.  GSI-I (Z-LLNle-CHO) inhibits γ-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemia.

Authors:  X Meng; K Matlawska-Wasowska; F Girodon; T Mazel; C L Willman; S Atlas; I-M Chen; R C Harvey; S P Hunger; S A Ness; S S Winter; B S Wilson
Journal:  Leukemia       Date:  2011-04-15       Impact factor: 11.528

Review 6.  The Link between Autoimmunity and Lymphoma: Does NOTCH Signaling Play a Contributing Role?

Authors:  Christina Arieta Kuksin; Lisa M Minter
Journal:  Front Oncol       Date:  2015-02-24       Impact factor: 6.244

Review 7.  The challenge of targeting notch in hematologic malignancies.

Authors:  Fiorela N Hernandez Tejada; Jorge R Galvez Silva; Patrick A Zweidler-McKay
Journal:  Front Pediatr       Date:  2014-06-10       Impact factor: 3.418

8.  The truncate mutation of Notch2 enhances cell proliferation through activating the NF-κB signal pathway in the diffuse large B-cell lymphomas.

Authors:  Xinxia Zhang; Yaoyao Shi; Yuanyuan Weng; Qian Lai; Taobo Luo; Jing Zhao; Guoping Ren; Wande Li; Hongyang Pan; Yuehai Ke; Wei Zhang; Qiang He; Qingqing Wang; Ren Zhou
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

9.  RBPJ is a novel target for rhabdomyosarcoma therapy.

Authors:  Hiroko Nagao; Takao Setoguchi; Sho Kitamoto; Yasuhiro Ishidou; Satoshi Nagano; Masahiro Yokouchi; Masahiko Abematsu; Naoya Kawabata; Shingo Maeda; Suguru Yonezawa; Setsuro Komiya
Journal:  PLoS One       Date:  2012-07-09       Impact factor: 3.240

10.  Synergistic induction of apoptosis by combination of BTK and dual mTORC1/2 inhibitors in diffuse large B cell lymphoma.

Authors:  Scott A Ezell; Michele Mayo; Teeru Bihani; Suprawee Tepsuporn; Suping Wang; Melissa Passino; Shaun E Grosskurth; Mike Collins; Julie Parmentier; Corinne Reimer; Kate F Byth
Journal:  Oncotarget       Date:  2014-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.